Global Subdermal Contraceptive Implants Market, Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029

“Global Subdermal Contraceptive Implants Market” is a recently produced market research report by marketResearch.biz after performing a detailed study on the global target market. In the report, various factors such as drivers, growth opportunities, restraints, revenue sources, details on key players, etc. are included in detail. The global subdermal contraceptive implants market has been segmented on the basis of region.

Request Covid - 19 Impact

Overview

Subdermal contraceptive implant is known as a type of hormonal birth control. In order to prevent pregnancy, implant releases the progestin hormone to body. By blocking release of eggs from ovaries, progestin prevents pregnancy. Besides, for preventing sperm from entering the uterus, it also thickens cervical mucus. Subdermal contraceptive implants include delivery of steroid progestin from rods or polymer capsules placed under skin. Subdermal contraceptive implant diffuses hormone out slowly but at a stable rate, and provide contraceptive effectiveness for around 1-5 years. However, the protection period mainly depends upon the type of polymer and specific progestin used. It is better to insert and remove two rods than six capsules and generally, both are effective for 5 years. There are many advantages for subdermal contraceptive implants such as long term contraceptive action which does not require any attention from users. Subdermal contraceptive implants are highly effective at a low dose without using estrogen. Another benefit of using subdermal contraceptive implants is that after the removal of implants, fertility id readily possible. According to the Guttmacher Institute, almost half a million women are using contraceptive implants. Apart from advantages, there are also advantages for subdermal contraceptive implants such as breast pain, headache, nausea, weight gain, infection where the implant was inserted, and ovarian cysts. These side effects are not as serious as they usually go away after a few months.

Dynamics

The major factors expected to drive growth of the subdermal contraceptive implant global market are increasing adoption of various advanced contraceptive methods, growing awareness about family planning and sexual health, and increase in initiatives from government. Rising unintended pregnancies and proportional growth in the number of abortions are burdening the government by adding healthcare costs. Hence, several governments have initiated different programs to make available and improve access to various contraception methods. Another factor driving growth of the market is popularity of long-acting various birth control methods. Different Major benefits and advantages of subdermal contraceptive implants such as high effectivity, speedy return of the natural fertility once removed the implant, cost-efficiency, and useful to women who are allergic to estragon are expected to further drive growth of the product in the global subdermal contraceptive implants market over the forecast period. Different governments are undertaking initiatives to make it accessible for consumers as it is cheaper and cuts costs in the healthcare sector. Numerous U.S. federal organizations have made it mandatory in health insurance coverages to increase availability of contraceptives. Al these factors are projected to increase demand for the product in the global subdermal contraceptive implants over the forecast period. In addition, various cheaper subdermal contraceptive implants such as Sino-implant (II) is projected to become popular in Africa and Asia, which is expected to further drive growth of the global subdermal contraceptive implants market over the forecast period.

Global Subdermal Contraceptive Implants Market Regional Analysis:

The North America market is projected to dominate the global subdermal contraceptive implants market regarding revenue share in terms of revenue over the forecast period. This growth can be attributed increasing awareness about contraceptives, high disposable income, supportive government schemes, technological advancements, rising demand for contraception, and increasing abortion rate.

Global Subdermal Contraceptive Implants Market Segmentation: 

By Type:

• Etonogestrel Implant
• Levonorgestrel Implant
• Others

By Application:

• Hospital
• Clinic
• Others

By region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Bayer AG
• Reckitt Benckiser Group plc
• Merck Sharp & Dohme Corp.
• Church & Dwight Co., Inc.
• Teva Pharmaceutical Industries, Ltd.
• Allergan plc
• Ansell Limited (Now Humanwell)
• The Female Health Company (a division of VERU Inc.)
• Karex Industries
• Mayer Laboratories
• Kessel Medintim GmbH
• Okamato Industries, Inc.